文献速递角膜与眼表疾病

原发DMEK失败后行超薄DSAEK的疗效观察

Outcomes of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) performed in eyes with failure of primary Descemet membrane endothelial keratoplasty (DMEK).
PubMed 文献 · Br J Ophthalmol · 2018-05-29

回顾性非对照介入病例系列纳入21只原发DMEK失败后行UT-DSAEK的眼,术后12个月无合并症眼中92% BSCVA≥20/25,平均内皮细胞丢失率38.9%,6个月中央植片厚度平均81±34 µm。结论认为UT-DSAEK有助于原发DMEK植片失败的处理,视觉康复与重复DMEK相当。

要点

  • 原发DMEK失败后行UT-DSAEK,12个月时无合并症眼92%达BSCVA≥20/25。
  • 术后12个月平均内皮细胞丢失率为38.9%(范围8%-57%)。
  • 术后6个月中央植片厚度平均81±34 µm(范围34-131 µm)。

核心结论

  • UT-DSAEK有助于原发DMEK植片失败的处理,视觉康复与重复DMEK相当。

研究设计与样本

  • 回顾性、非对照介入病例系列,于三级医院开展,纳入21只原发DMEK失败后行UT-DSAEK的眼。

主要发现

  • 仅考虑无合并症眼(21只中17只)时,UT-DSAEK术后12个月BSCVA≥20/25为12/13只眼(92%),≥20/20为4/13只眼(30%)。
  • UT-DSAEK术后12个月平均内皮细胞丢失率为38.9%(范围8%-57%)。
  • UT-DSAEK术后6个月中央植片厚度平均81±34 µm(范围34-131 µm)。
  • 无术中并发症记录;术后1例(第8号)出现植片皱褶,于UT-DSAEK后2天处理。
  • 4例发生人工晶状体(IOL)混浊,其中2例行IOL置换;无其他术后并发症记录。

临床怎么用

  • 原文结论认为UT-DSAEK可用于原发DMEK植片失败后的处理,视觉康复与重复DMEK相当。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To evaluate the outcomes of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) performed in eyes after failure of primary Descemet membrane endothelial keratoplasty (DMEK). METHODS: This was a retrospective, non-comparative interventional case series done in a tertiary care hospital. The study group included 21 eyes of patients which underwent UT-DSAEK following the failure of primary DMEK. Outcome measures included best spectacle-corrected visual acuity (BSCVA) and endothelial cell density (ECD) both recorded 6 and 12 months postoperatively as well as central graft thickness (CGT) measured 6 months after UT-DSAEK. RESULTS: When considering only eyes without comorbidities (17 of 21), 12 months after UT-DSAEK, BSCVA was ≥20/25 in 12/13 (92%) eyes and ≥20/20 in 4/13 (30%) eyes. Mean ECD loss rate was 38.9% at 12 months postoperatively (range 8%-57%). Six months postoperatively, CGT averaged at 81±34 µm (range 34-131 µm). No intraoperative complications were recorded. Postoperatively, one patient (no. 8) had graft wrinkles that were fixed 2 days following UT-DSAEK. Four patients have developed intraocular lens (IOL) opacification, and two of them underwent IOL exchange. No other postoperative complications were recorded. CONCLUSIONS: UT-DSAEK is instrumental in the management of primary DMEK graft failure, allowing visual rehabilitation which is comparable with that of repeat DMEK.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Graffi S, Leon P, Nahum Y, et al. Outcomes of ultrathin Descemet stripping automated endothelial keratoplasty (UT-DSAEK) performed in eyes with failure of primary Descemet membrane endothelial keratoplasty (DMEK). Br J Ophthalmol. 2018. PMID: 29844085. doi:10.1136/bjophthalmol-2017-311834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。